Skip to main content

Table 1

From: Computational methods and resources for the interpretation of genomic variants in cancer

Cancer Type Donors Total Unique Mutations Total Recurrent Mutations Donors with Recurrent Mutations
BLCA 233 53,638 737 (1.4%) 219 (94.0%)
BOCA 66 1,422 7 (0.5%) 39 (59.1%)
BRCA 1,071 275,612 1,252 (0.5%) 929 (86.7%)
CLLE 109 5,292 4 (0.1%) 10 (9.2%)
CMDI 129 86 13 (15.1%) 113 (87.6%)
COAD 216 105,786 3,896 (3.7%) 215 (99.5%)
EOPC 11 25,575 2 (0.0%) 4 (36.4%)
ESAD 95 1,780,883 25,425 (1.4%) 95 (100.0%)
ESCA 88 7,256 17 (0.2%) 37 (42.0%)
GACA 9 1,014 0 (0.0%) 0 (0.0%)
GBM 268 19,852 324 (1.6%) 260 (97.0%)
KIRC 404 26,371 688 (2.6%) 372 (92.1%)
KIRP 156 12,932 218 (1.7%) 144 (92.3%)
LAML 75 60,203 7,623 (12.7%) 71 (94.7%)
LGG 279 13,083 432 (3.3%) 278 (99.6%)
LIAD 30 917 11 (1.2%) 19 (63.3%)
LICA 29 747,334 27,107 (3.6%) 6 (20.7%)
LINC 244 437,403 6003 (1.4%) 244 (100.0%)
LIRI 208 2,124,689 4161 (0.2%) 208 (100.0%)
LUSC 289 125,351 1400 (1.1%) 268 (92.7%)
MALY 44 311,297 686 (0.2%) 44 (100.0%)
NBL 41 137 2 (1.5%) 4 (9.8%)
ORCA 50 5,604 35 (0.6%) 38 (76.0%)
OV 181 919,769 869 (0.1%) 119 (65.7%)
PACA 504 1,630,944 6,098 (0.4%) 500 (96.5%)
PAEN 35 112,823 804 (0.7%) 32 (91.4%)
PBCA 248 130,608 1,231 (0.9%) 89 (35.9%)
PRAD 264 90,599 776 (0.9%) 256 (96.7%)
READ 80 23,499 556 (2.4%) 80 (100.0%)
RECA 105 475,986 6,067 (1.3%) 95 (90.5%)
SKCM 323 226,850 11,908 (5.2%) 323 (100.0%)
STAD 289 142,496 3,441 (2.4%) 276 (95.5%)
THCA 411 51,759 4,619 (8.9%) 311 (75.7%)
PanCancer 6,584 9,871,474 171,314 (1.7%) 6,296 (95.6%)
  1. Somatic mutations in 33 tumor types from 42 projects from the ICGC release 17 (September 2014). Donors: total number of individual for each tumor type. Total Unique Mutations: number of somatic mutations in the whole genome for each cancer type removing repetitions. Total Recurrent Mutations: fraction of Total Unique Mutations observed at least in two donors for the same tumor type. Donors with Recurrent Mutations: fraction of donors with at least one recurrent somatic mutation.